Procept Biorobotics Corp Stock Today
| PRCT Stock | USD 58.22 0.71 1.20% |
PerformanceVery Weak
| Odds Of DistressLow
|
Procept Biorobotics is selling for under 58.22 as of the 26th of June 2025; that is 1.2% down since the beginning of the trading day. The stock's last reported lowest price was 57.88. Procept Biorobotics has about a 23 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 27th of May 2025 and ending today, the 26th of June 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 15th of September 2021 | Category Healthcare | Classification Health Care |
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California. Procept Biorobotics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. The company has 55.33 M outstanding shares of which 6.1 M shares are at this time shorted by private and institutional investors with about 7.31 trading days to cover. More on Procept Biorobotics Corp
Moving together with Procept Stock
Moving against Procept Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Procept Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO President | Reza Zadno | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsProcept Biorobotics can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Procept Biorobotics' financial leverage. It provides some insight into what part of Procept Biorobotics' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Procept Biorobotics Corp (PRCT) is traded on NASDAQ Exchange in USA. It is located in 150 Baytech Drive, San Jose, CA, United States, 95134 and employs 756 people. Procept Biorobotics is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.22 B. Procept Biorobotics Corp conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 55.33 M outstanding shares of which 6.1 M shares are at this time shorted by private and institutional investors with about 7.31 trading days to cover.
Procept Biorobotics Corp currently holds about 269.81 M in cash with (99.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.05.
Check Procept Biorobotics Probability Of Bankruptcy
Ownership AllocationProcept Biorobotics owns a total of 55.33 Million outstanding shares. The majority of Procept Biorobotics Corp outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Procept Biorobotics Corp to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Procept Biorobotics. Please pay attention to any change in the institutional holdings of Procept Biorobotics Corp as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Procept Ownership Details
Procept Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Bank Of America Corp | 2025-03-31 | 809.5 K | |
| Axa Sa | 2025-03-31 | 787 K | |
| Westfield Capital Management Company, L.p. | 2025-03-31 | 748.6 K | |
| Jpmorgan Chase & Co | 2025-03-31 | 716.3 K | |
| Champlain Investment Partners, Llc | 2025-03-31 | 676.2 K | |
| Mirae Asset Global Etfs Holdings Ltd. | 2025-03-31 | 661.8 K | |
| Lord, Abbett & Co Llc | 2025-03-31 | 544.7 K | |
| Millennium Management Llc | 2025-03-31 | 543 K | |
| Federated Hermes Inc | 2025-03-31 | 539.2 K | |
| Fmr Inc | 2025-03-31 | 8.2 M | |
| Vanguard Group Inc | 2025-03-31 | 5.1 M |
Procept Biorobotics Historical Income Statement
Procept Stock Against Markets
Procept Biorobotics Corporate Management
| Matthew CFA | Vice Relations | Profile | |
| Christofer Christoforou | Senior Operations | Profile | |
| Hisham Shiblaq | Executive Officer | Profile | |
| Stacey Porter | Chief Officer | Profile | |
| Minni Vittal | VP Officer | Profile |
Additional Tools for Procept Stock Analysis
When running Procept Biorobotics' price analysis, check to measure Procept Biorobotics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procept Biorobotics is operating at the current time. Most of Procept Biorobotics' value examination focuses on studying past and present price action to predict the probability of Procept Biorobotics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procept Biorobotics' price. Additionally, you may evaluate how the addition of Procept Biorobotics to your portfolios can decrease your overall portfolio volatility.